Cite
Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?
MLA
Rallis, Efstathios, et al. “Onset of Palmoplantar Pustular Psoriasis While on Adalimumab for Psoriatic Arthritis: A ‘Class Effect’ of TNF-α Antagonists or Simply an Anti-Psoriatic Treatment Adverse Reaction?” Journal of Dermatological Treatment, vol. 21, no. 1, Jan. 2010, pp. 3–5. EBSCOhost, https://doi.org/10.3109/09546630902882089.
APA
Rallis, E., Korfitis, C., Stavropoulou, E., & Papaconstantis, M. (2010). Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction? Journal of Dermatological Treatment, 21(1), 3–5. https://doi.org/10.3109/09546630902882089
Chicago
Rallis, Efstathios, Chrysovalantis Korfitis, Evgenia Stavropoulou, and Markos Papaconstantis. 2010. “Onset of Palmoplantar Pustular Psoriasis While on Adalimumab for Psoriatic Arthritis: A ‘Class Effect’ of TNF-α Antagonists or Simply an Anti-Psoriatic Treatment Adverse Reaction?” Journal of Dermatological Treatment 21 (1): 3–5. doi:10.3109/09546630902882089.